A COMBINED DELAYED AND EXTENDED RELEASE FORMULATION OF MESALAMINE DEMONSTRATES BETTER CLINICAL OUTCOME IN DISTAL , ACTIVE ULCERATIVE COLITIS THAN A SOLELY DELAYED RELEASE FORMULATION

(1) st Dept of Medicine, Monach University, Box Hill Hospital, Box Hill (VIC), Australia

(2) Internal Medicine, Ev Krankenhaus Kalk, Cologne

(3) Clinical Research and Development, Dr Falk Pharma GmbH, Freibrug, Germany



This item was part of the IMMFLAMMATORY BOWEL DISEASE II session at Gastro 2009 UEGW/WCOG London (17th UEGW)

This item can be cited as: Gut 2009; 58 (Suppl II) A325